Tue, 07/05/2016
The U.S. Food and Drug Administration (FDA) approved a modified Risk Evaluation and Mitigation Strategy (REMS) for Sabril or vigabatrin. There is no change in the risk for visual problems with Sabril, but the process for monitoring and reporting has...
Emergency Plan
Wed, 06/29/2016
Status Epilepticus is defined as a seizure lasting longer than 5 minutes, or two or more seizures happening without improvement in between. The first definition is based on time. Older classifications defined status epilepticus as 10 or 20...
Summer Fun
Wed, 06/29/2016
It’s summer time and the 4th of July is right around the corner. For many, it’s a time to get together with friends and family, go on vacation, watch fireworks, have a cookout, or go to the beach.   This sounds like fun, but for someone with...
Mon, 06/27/2016
The Epilepsy Foundation is pleased to hear positive results of the first randomized, double-blind, placebo-controlled Phase 3 clinical trial of GW Pharmaceuticals’ investigational medicine Epidiolex® (cannabidiol or CBD) for the treatment of Lennox-...
Young Adults
Wed, 06/22/2016
Some things never change. Children who grow up with seizures go off to school or look for job and are hit with lots of new responsibilities and challenges, all because of their epilepsy. Or a young adult develops seizures for the first time and is...

Pages